Of 40 participants, concerns included maintaining access to insulin (n=26, 65.0%), insulin delivery devices (n=15, 37.5%), blood glucose testing strips (n=17, 42.5%) and standard diabetes healthcare care reviews (n=25, 62.5%). Here, INS is linked to diabetes mellitus.